Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Anne Janeway, M.D.

Concepts (389)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteosarcoma3720238817.370 Why?
Bone Neoplasms45202325295.450 Why?
Gastrointestinal Stromal Tumors1620216432.790 Why?
Neuroectodermal Tumors, Primitive, Peripheral42023452.110 Why?
Gastrointestinal Neoplasms820219901.250 Why?
Succinate Dehydrogenase620161461.170 Why?
Neoplasm Recurrence, Local21202392390.950 Why?
Neoplasms232023216830.920 Why?
Clinical Trials, Phase II as Topic320166290.920 Why?
Child922023777090.900 Why?
Fibromatosis, Aggressive320201180.890 Why?
Receptor, Platelet-Derived Growth Factor alpha620193790.880 Why?
Sarcoma9202318970.860 Why?
Molecular Targeted Therapy12202227270.820 Why?
Oncogene Proteins, Fusion8202315810.800 Why?
Neoplasms, Muscle Tissue12021830.770 Why?
High-Throughput Nucleotide Sequencing8202335970.770 Why?
Medical Oncology9202322650.750 Why?
Proto-Oncogene Proteins c-kit720197760.730 Why?
Furans220181940.730 Why?
Ketones220181880.720 Why?
Antineoplastic Agents122020136950.710 Why?
Paraganglioma520221430.680 Why?
Antineoplastic Combined Chemotherapy Protocols182023115240.640 Why?
Receptor, IGF Type 1420193900.630 Why?
Central Nervous System Neoplasms220238950.610 Why?
Adolescent602023857810.560 Why?
Doxorubicin7202322340.560 Why?
Clinical Trials as Topic9202179130.530 Why?
Genomics15202357200.510 Why?
Soft Tissue Neoplasms5202313630.500 Why?
Pediatrics5202034750.490 Why?
Protein-Tyrosine Kinases3202224550.490 Why?
Germ-Line Mutation9202317880.480 Why?
Marketing of Health Services120151530.470 Why?
Gene Fusion320223710.470 Why?
Adrenal Gland Neoplasms420227400.460 Why?
Protein Kinase Inhibitors10202355350.450 Why?
Proto-Oncogene Proteins3202245540.440 Why?
Antibiotics, Antineoplastic120166920.430 Why?
Immunoconjugates120199010.420 Why?
Pheochromocytoma320223370.410 Why?
Sarcoma, Clear Cell22023760.410 Why?
Humans12720237443430.390 Why?
Child, Preschool332023410060.390 Why?
Mutation202023297860.390 Why?
Neoadjuvant Therapy3201927280.380 Why?
Piperazines3201624880.380 Why?
Ambulatory Care Facilities120179330.370 Why?
Cell Respiration120102010.370 Why?
Gene Amplification3202310630.360 Why?
DNA Mutational Analysis3201641860.340 Why?
Lung Neoplasms42023131020.330 Why?
Pyrimidines2201229420.320 Why?
Feasibility Studies2202150780.310 Why?
Vincristine4202310390.310 Why?
Tissue Banks320201840.300 Why?
Prognosis182023290630.300 Why?
Young Adult302023564300.300 Why?
Amyloid Precursor Protein Secretases220225840.300 Why?
Fibrosarcoma220203480.290 Why?
Patient Selection2201742150.290 Why?
Electron Transport Complex II32019480.280 Why?
Ovarian Neoplasms1202348380.280 Why?
Proteins1202161030.280 Why?
TOR Serine-Threonine Kinases2201721090.280 Why?
Cyclin-Dependent Kinase 4320185380.270 Why?
Infant212022351360.270 Why?
Genetic Predisposition to Disease72022174460.260 Why?
Phosphatidylinositol 3-Kinases1201429380.250 Why?
Antibodies, Monoclonal3202392740.240 Why?
Female5320233801940.240 Why?
Rare Diseases220215530.240 Why?
Genetic Testing3201734440.240 Why?
Disease-Free Survival5202368950.230 Why?
National Cancer Institute (U.S.)520232880.230 Why?
Male4920223501180.230 Why?
Myofibromatosis12023300.220 Why?
Pyrroles1200911460.220 Why?
Receptor, Platelet-Derived Growth Factor beta220231880.220 Why?
Hematologic Neoplasms1201418320.210 Why?
Internet1201530640.210 Why?
Genome, Human2201744200.210 Why?
Plasma Cell Granuloma, Pulmonary12021130.210 Why?
Adult3620232140550.210 Why?
Glomus Tumor12022660.200 Why?
Receptor Protein-Tyrosine Kinases4202216600.200 Why?
Rhabdoid Tumor120232120.200 Why?
Granuloma, Plasma Cell12022840.200 Why?
Topotecan120211370.200 Why?
Neoplasms, Neuroepithelial12021450.200 Why?
Indenes12021570.190 Why?
Loss of Heterozygosity120236840.190 Why?
Indoles1200918390.190 Why?
Polycythemia120211260.190 Why?
Pelvic Neoplasms120222540.190 Why?
Tandem Repeat Sequences120211850.190 Why?
Tetrahydronaphthalenes12020890.180 Why?
Ifosfamide320232280.180 Why?
Brain Neoplasms4202388630.180 Why?
DEAD-box RNA Helicases220203750.180 Why?
Biomedical Research3202133090.180 Why?
Sequence Analysis, RNA4202120120.180 Why?
Neoplasms, Unknown Primary120201040.180 Why?
BRCA1 Protein2202311490.170 Why?
Myofibroma12019500.170 Why?
Cyclophosphamide2202322420.170 Why?
Cyclin-Dependent Kinase 6220183220.170 Why?
Chromosomes, Human, Pair 14220172990.170 Why?
Nomograms120202280.170 Why?
Benzamides3202313790.170 Why?
Valine120204130.160 Why?
Drug Resistance, Neoplasm4201951720.160 Why?
Proto-Oncogene Proteins c-ret120202200.160 Why?
Carcinoma, Medullary120191230.160 Why?
Kidney Neoplasms3202142620.160 Why?
BRCA2 Protein120237940.160 Why?
Gene Expression Regulation, Neoplastic6202084280.160 Why?
Treatment Outcome112019631140.160 Why?
Epigenomics320199030.160 Why?
Ribonuclease III120202750.160 Why?
Parotid Neoplasms120191550.160 Why?
Nephroma, Mesoblastic12017250.160 Why?
Resource Allocation120203410.160 Why?
Dystrophin120192850.160 Why?
Legislation, Drug120202060.160 Why?
Neoplasm Metastasis6201948510.160 Why?
Tumor Suppressor Protein p533201929480.150 Why?
Glioma2202234010.150 Why?
Benzimidazoles120228500.140 Why?
Vascular Endothelial Growth Factor Receptor-2120195460.140 Why?
Microtubule-Associated Proteins2202210860.140 Why?
Informed Consent120239950.140 Why?
Li-Fraumeni Syndrome120171140.140 Why?
von Hippel-Lindau Disease120171520.140 Why?
Etoposide320236410.130 Why?
Basic Helix-Loop-Helix Transcription Factors1202111140.130 Why?
Karyopherins120161370.130 Why?
SEER Program1202015080.130 Why?
Specimen Handling120206940.130 Why?
Retrospective Studies152023774490.130 Why?
Carcinoma, Neuroendocrine120193320.130 Why?
Disease Models, Animal22014180290.130 Why?
Genomic Imprinting120173280.130 Why?
Survival Rate52019127880.130 Why?
Pelvic Bones120172650.130 Why?
United States Food and Drug Administration3202215840.130 Why?
Histone-Lysine N-Methyltransferase120196700.130 Why?
Infant, Newborn82023256250.120 Why?
RNA, Neoplasm120177690.120 Why?
Pyrazines1201912300.120 Why?
Databases, Factual3202377290.110 Why?
Cell Line, Tumor72022166890.110 Why?
Imidazoles1201912060.110 Why?
Endpoint Determination120166010.110 Why?
Follow-Up Studies82020390500.110 Why?
Age of Onset1201932710.110 Why?
Repressor Proteins2202130230.110 Why?
Cisplatin3201916620.110 Why?
Leukemia1202115110.110 Why?
Proteasome Endopeptidase Complex1201913380.110 Why?
DNA Copy Number Variations2201919410.110 Why?
Glucocorticoids1202121070.100 Why?
Drug Evaluation, Preclinical2201613750.100 Why?
Serine Endopeptidases1201710720.100 Why?
Gastrectomy120166630.100 Why?
Patient Participation1202114570.100 Why?
Methotrexate3201917270.100 Why?
Extremities120178650.100 Why?
Combined Modality Therapy4202286420.100 Why?
United States132023698720.100 Why?
Receptors, Cytoplasmic and Nuclear120168710.100 Why?
Cerebellar Neoplasms120165870.100 Why?
Prospective Studies92023532880.100 Why?
Genetic Heterogeneity120147330.100 Why?
Polyethylene Glycols1201611820.100 Why?
Cell Survival1202158820.100 Why?
Medulloblastoma120166830.100 Why?
Gene Dosage2201712520.090 Why?
Syndrome2202132510.090 Why?
Membrane Proteins3201778800.090 Why?
RNA Processing, Post-Transcriptional120134360.090 Why?
Age Factors42020183700.090 Why?
Antidotes120101380.090 Why?
MicroRNAs2201737520.080 Why?
In Situ Hybridization, Fluorescence3202126490.080 Why?
Treatment Failure2201726180.080 Why?
Germ Cells220236310.080 Why?
Heart Neoplasms120123740.080 Why?
Nasopharyngeal Neoplasms120112860.080 Why?
Ecosystem220234740.080 Why?
Polymorphism, Single Nucleotide42017155190.080 Why?
Mediastinal Neoplasms120114230.080 Why?
Protein Subunits120109590.070 Why?
Disease Progression52021132840.070 Why?
Survivors2202322910.070 Why?
Translocation, Genetic2202314200.070 Why?
Dose-Response Relationship, Drug12019109430.070 Why?
Head and Neck Neoplasms1202027340.070 Why?
Pedigree1201446440.070 Why?
Diagnosis, Differential12021129590.070 Why?
Thyroid Neoplasms1201922820.070 Why?
Cell Cycle Proteins1201734620.070 Why?
Neurotoxicity Syndromes120102900.070 Why?
Oncogenes2202212650.070 Why?
Mice, Nude3201936890.060 Why?
Immunotherapy2202144450.060 Why?
Immunohistochemistry32019113660.060 Why?
Melanoma1202355100.060 Why?
Risk Assessment32020233380.060 Why?
Receptor, erbB-21201424160.060 Why?
Neoplastic Cells, Circulating120119340.060 Why?
Pancreatic Neoplasms1202152560.060 Why?
Forecasting1201329510.060 Why?
Computer Simulation1201761960.060 Why?
Neoplasm Transplantation2201920850.060 Why?
Clinical Protocols2202214620.060 Why?
Gene Expression Profiling5201794380.060 Why?
Biopsy3202067560.060 Why?
Infertility120106550.060 Why?
Adenocarcinoma1202063640.060 Why?
Cyclic AMP Response Element Modulator12023870.050 Why?
Blotting, Western1201051790.050 Why?
Nuclear Proteins2202358530.050 Why?
Hearing Loss120107650.050 Why?
Attitude of Health Personnel1201638430.050 Why?
Normetanephrine12021260.050 Why?
DNA Damage2202224320.050 Why?
Neoplasms, Second Primary1201010610.050 Why?
Dogs2201939120.050 Why?
Inflammation12021106380.050 Why?
3-Iodobenzylguanidine120221150.050 Why?
Hematopoietic Stem Cell Transplantation1201954420.050 Why?
Enzyme Activation1200737010.050 Why?
Research Design2201759870.050 Why?
Microphthalmia-Associated Transcription Factor120232520.050 Why?
Trismus12020330.050 Why?
Chromogranins120211600.050 Why?
DNA Methylation4201742860.050 Why?
Desmoplastic Small Round Cell Tumor12020260.050 Why?
Sacrum120222880.050 Why?
RNA-Binding Protein EWS120212160.050 Why?
Survival Analysis32018102520.050 Why?
Signal Transduction52021234030.050 Why?
Cell Differentiation22023114830.050 Why?
Poly(ADP-ribose) Polymerases120224400.050 Why?
Oncogene Proteins220177490.040 Why?
Middle Aged1320212133830.040 Why?
Oncogene Fusion12020990.040 Why?
Polymerase Chain Reaction1200961710.040 Why?
RNA2202227490.040 Why?
Mice62022811830.040 Why?
Codon120216110.040 Why?
Phosphorylation1201084360.040 Why?
Xenograft Model Antitumor Assays2201835570.040 Why?
Cell Cycle2201929670.040 Why?
Receptor, Notch1120225020.040 Why?
Mitogen-Activated Protein Kinase Kinases120226480.040 Why?
Adrenal Glands120215460.040 Why?
Animals920221687570.040 Why?
Cell Proliferation12014104810.040 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120229030.040 Why?
Kidney Diseases1201021490.040 Why?
RNA Interference2201928890.040 Why?
Workers' Compensation119991520.040 Why?
Pathology, Molecular120213260.040 Why?
Calcitonin120193360.040 Why?
DNA Helicases120238590.040 Why?
Endothelial Cells1201134790.040 Why?
Carbazoles120192260.040 Why?
Proportional Hazards Models32017123540.040 Why?
Radionuclide Imaging1202220310.040 Why?
Cohort Studies52021405610.040 Why?
Drug Labeling120202330.040 Why?
GTP-Binding Proteins120229700.040 Why?
Stem Cells1201135670.040 Why?
American Cancer Society12017610.040 Why?
Insulin-Like Growth Factor Binding Protein 212017760.040 Why?
Utah120171260.040 Why?
Breast Neoplasms22022208220.040 Why?
Mitogen-Activated Protein Kinases1202212850.040 Why?
Heart Diseases1201027880.040 Why?
Receptors, Platelet-Derived Growth Factor120171800.040 Why?
Proto-Oncogene Proteins c-ets120173180.040 Why?
Receptors, Fibroblast Growth Factor120171850.040 Why?
Sequence Analysis, DNA2201848030.040 Why?
Necrosis1202016430.030 Why?
Minor Histocompatibility Antigens120172980.030 Why?
Comparative Genomic Hybridization120174960.030 Why?
MAP Kinase Kinase Kinases120172610.030 Why?
Safety1202011860.030 Why?
Carpal Tunnel Syndrome119993000.030 Why?
Exons1202124370.030 Why?
Educational Status1202325400.030 Why?
Practice Guidelines as Topic1201272790.030 Why?
Molecular Diagnostic Techniques120196020.030 Why?
Hydrazines120162260.030 Why?
Proto-Oncogene Proteins p21(ras)1202216920.030 Why?
Transplantation, Autologous1201921240.030 Why?
Drug Synergism1201817920.030 Why?
Ubiquitin Thiolesterase120174490.030 Why?
Microarray Analysis120177670.030 Why?
Radiotherapy, Adjuvant1201917700.030 Why?
Ubiquitin120198520.030 Why?
Cytoskeletal Proteins1201913640.030 Why?
Data Collection1202333410.030 Why?
Drug Screening Assays, Antitumor120167300.030 Why?
Drug Approval120207420.030 Why?
Fluorodeoxyglucose F181202220160.030 Why?
Early Detection of Cancer2201730860.030 Why?
National Institutes of Health (U.S.)120167800.030 Why?
Motivation1202319710.030 Why?
Computational Biology2201735210.030 Why?
Aged720211632800.030 Why?
Aged, 80 and over42021577760.030 Why?
Small Molecule Libraries120187200.030 Why?
Europe1201933390.030 Why?
Pneumonectomy1201910940.030 Why?
DNA Repair1202220460.030 Why?
Models, Biological2202195830.030 Why?
Ubiquitin-Protein Ligases1202218610.030 Why?
Self Efficacy120166160.030 Why?
Radiopharmaceuticals1202226450.030 Why?
Risk Factors42020722900.030 Why?
Neoplasm Proteins2201737030.030 Why?
DNA, Neoplasm1201717580.030 Why?
Tumor Suppressor Proteins1202228490.030 Why?
Piperidines1201916020.020 Why?
Base Sequence12022127970.020 Why?
Immunoenzyme Techniques1201417990.020 Why?
Regression Analysis1202064590.020 Why?
Cardiovascular Surgical Procedures120121940.020 Why?
Lymphatic Metastasis1201829240.020 Why?
Triazoles120169110.020 Why?
Genes, Tumor Suppressor1201510970.020 Why?
Reproducibility of Results22021199050.020 Why?
ROC Curve1201735270.020 Why?
Chromosome Aberrations1201618130.020 Why?
Neoplasm Invasiveness1201736160.020 Why?
Genomic Instability120136950.020 Why?
Acetylation1201110850.020 Why?
Time Factors22020400750.020 Why?
Hydroxamic Acids120114940.020 Why?
Epigenesis, Genetic1202136470.020 Why?
Alleles1201969330.020 Why?
Health Policy1202026610.020 Why?
Chemotherapy, Adjuvant1201634790.020 Why?
Prevalence12023152260.020 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120106270.020 Why?
Gene Knockdown Techniques1201116550.020 Why?
Patient Education as Topic1201622780.020 Why?
Proteomics1201936380.020 Why?
Positron-Emission Tomography1202262340.020 Why?
Cluster Analysis1201327150.020 Why?
Kaplan-Meier Estimate1201665380.020 Why?
Carcinoma1201723750.020 Why?
Histone Deacetylase Inhibitors120117890.020 Why?
Bone Marrow1201629480.020 Why?
Promoter Regions, Genetic1201658670.020 Why?
Pyridines1201628250.020 Why?
Recurrence1201683400.010 Why?
Boston1201793130.010 Why?
Research1201219990.010 Why?
Transcription Factors12023122080.010 Why?
Kidney1201971860.010 Why?
Transcription, Genetic1201777220.010 Why?
T-Lymphocytes12020101800.010 Why?
Transfection1201158920.010 Why?
Transplantation, Heterologous1201123820.010 Why?
Parents1201634070.010 Why?
RNA, Small Interfering1201135050.010 Why?
Quality of Life12022128040.010 Why?
Histones1201125990.010 Why?
Magnetic Resonance Imaging22021354210.010 Why?
Proto-Oncogene Proteins B-raf1201020430.010 Why?
Antigens, CD1201140260.010 Why?
Flow Cytometry1201159740.010 Why?
Tomography, X-Ray Computed12022201290.010 Why?
Randomized Controlled Trials as Topic1201499590.010 Why?
RNA, Messenger12013130330.010 Why?
New York119998860.010 Why?
Genotype12010129510.010 Why?
Cross-Sectional Studies12016250430.010 Why?
Carcinoma, Squamous Cell1201140340.010 Why?
Insurance Claim Review119997200.010 Why?
Case-Control Studies12011217460.010 Why?
Socioeconomic Factors1199977850.000 Why?
Logistic Models11999134080.000 Why?
Health Services Accessibility1199951370.000 Why?
Janeway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (389)
Explore
_
Co-Authors (164)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.